We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$9.05B
AUM Growth
+$2.61B
Cap. Flow
+$2.57B
Cap. Flow %
28.36%
Top 10 Hldgs %
33.38%
Holding
1,260
New
320
Increased
653
Reduced
168
Closed
80

Sector Composition

Rank Sector Weight
1 Technology 12.55%
2 Healthcare 8.3%
3 Financials 7.53%
4 Industrials 6.18%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTA
1151
Strata Critical Medical Inc
SRTA
$445M
$45K ﹤0.01%
10,000
BLUE
1152
DELISTED
bluebird bio
BLUE
$45K ﹤0.01%
540
-94
-15% -$7.29K
BTG icon
1153
B2Gold
BTG
$5.16B
$45K ﹤0.01%
+13,288
New +$55.5K
HYFM icon
1154
Hydrofarm Holdings
HYFM
$3.19M
$42K ﹤0.01%
1,200
GOL
1155
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$40K ﹤0.01%
+11,684
New +$66.1K
ABEV icon
1156
Ambev
ABEV
$47.4B
$38K ﹤0.01%
15,026
-69,809
-82% -$199K
THER
1157
DELISTED
THERATECHNOLOGIES INC COM
THER
$38K ﹤0.01%
16,947
CTHR
1158
DELISTED
Charles & Colvard Ltd
CTHR
$29K ﹤0.01%
+2,380
New +$33.4K
DNTH icon
1159
Dianthus Therapeutics
DNTH
$5.71B
$24K ﹤0.01%
1,250
LTCH
1160
DELISTED
Latch, Inc. Common Stock
LTCH
$21K ﹤0.01%
18,642
+4,800
+35% +$12.3K
LAB icon
1161
Standard BioTools
LAB
$303M
$19K ﹤0.01%
12,000
-100
-0.8% -$247
ENIC icon
1162
Enel Chile
ENIC
$6.05B
$18K ﹤0.01%
+16,128
New +$22.2K
TCRT icon
1163
Alaunos Therapeutics
TCRT
$4.71M
$17K ﹤0.01%
91
BODI icon
1164
The Beachbody Company
BODI
$79.1M
$16K ﹤0.01%
262
+10
+4% +$810
BRMK.WS
1165
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$16K ﹤0.01%
213,500
CATX icon
1166
Perspective Therapeutics
CATX
$322M
$12K ﹤0.01%
4,000
MUX icon
1167
McEwen Inc
MUX
$1.04B
$10K ﹤0.01%
+2,322
New +$14.5K
SNDL icon
1168
Sundial Growers
SNDL
$351M
$5K ﹤0.01%
1,618
+373
+30% +$1.65K
TLPH icon
1169
Talphera
TLPH
$65.4M
$5K ﹤0.01%
+1,015
New +$4.72K
UAMY icon
1170
United States Antimony
UAMY
$808M
$4K ﹤0.01%
10,000
-400
-4% -$174
CSCI
1171
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$4K ﹤0.01%
200
ZOM
1172
DELISTED
Zomedica Corp.
ZOM
$4K ﹤0.01%
20,000
NOACW
1173
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$1K ﹤0.01%
+22,000
New +$2.49K
AAXJ icon
1174
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
-3,470
Closed -$260K
AFRM icon
1175
Affirm
AFRM
$24.5B
-5,757
Closed -$267K

Similar funds

Cerity Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Cerity Partners held 1,260 positions worth $9.05B, up 41% from $6.44B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cerity Partners deployed $2.57B of net new capital in Q2 2022, opening 320 new positions and adding to 653 existing holdings. Its largest new stake was Invesco QQQ Trust: 244,839 shares worth $68.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard FTSE All-World ex-US ETF, an estimated $27.6M trimmed.

  • Cerity Partners's largest Q2 2022 buy was Invesco QQQ Trust: 244,839 shares worth $68.7M.
  • Cerity Partners added most to Apple in Q2 2022, an estimated $143M increase.
  • Cerity Partners's biggest Q2 2022 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $27.6M.
  • Cerity Partners fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $653M.
  • Cerity Partners's ten largest holdings make up 33% of its $9.05B portfolio in Q2 2022.
  • Cerity Partners opened 320 new positions and closed 80 in Q2 2022.
  • Cerity Partners's portfolio value rose 41% quarter-over-quarter to $9.05B.

Based on Cerity Partners's 13F filing for Q2 2022, filed 10 Aug 2022.